| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Canada | 2 | |
| #3 | Australia | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Ireland | 1 | |
| #6 | Japan | 1 | |
| #7 | Netherlands | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Unspecified technologies | |
| #5 | Climate change adaptation technologies | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Moser Bernhard | 9 |
| #2 | Loetscher Marcel | 9 |
| #3 | Mackay Charles R | 5 |
| #4 | Qin Shixin | 5 |
| #5 | Baggiolini Marco | 1 |
| #6 | Olsen Henrik S | 1 |
| #7 | Kreider Brent L | 1 |
| #8 | Ruben Steven M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO9811218A1 | Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use | |
| US6140064A | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 | |
| IE893896L | Neutrophil-activating peptide-2 |